PIGV

Across TCGA pan-cancer cohorts, PIGV mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated PIGV data layer compared with 20 for mass-spec protein and 1 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher PIGV mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated PIGV expression acts as an unfavorable survival marker.

LUAD are the cancer types where PIGV mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	II,III,IV	0.135	0.797	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

PIGV–LUAD (DFS)

Open the LUAD breakdown →